Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum β-lactamase-producing organisms

Journal of Microbiology, Immunology and Infection

Volumn 36, Issue 3, 2003, Pages 182-186

  Lan, Chi Kin ^a   Hsueh, Po Ren ^b   Wong, Wing Wai ^c   Fung, Chang Phone ^c   Lau, Ya Tin ^d   Yeung, Jimmy Y K ^d   Young, Grace T ^d   Su, Ching Chyuan ^d  

^a PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TIAN SHENG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Ceftazidime; Extended spectrum lactamase; Klebsiella pneumoniae; Piperacillin tazobactam

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; IMIPENEM; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM ISOLATE; DRUG UTILIZATION; ENDEMIC DISEASE; EPIDEMIC; ESCHERICHIA COLI; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; NONHUMAN; PERSISTENT INFECTION; PROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFTAZIDIME; CEPHALOSPORIN RESISTANCE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; PENICILLANIC ACID; PIPERACILLIN; PROSPECTIVE STUDIES; TAIWAN;

EID: 0142106837     PISSN: 02532662     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jacoby GA, Medeiros AA. More extended- spectrum β-lactamases. Antimicrob Agents Chemother 1991;35:1697-704.
2. Burwen DR, Banerjee SN, Gaynes RP. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. J Infect Dis 1944;170:1622-5.
3. Meyer KS, Urban C, Eagan JA, Raha JJ. Nosocomial outbreak of infection resistant to late-generation cephalosporins. Ann Intern Med 1933;119:353-8.
4. Rice LB, Willey SH, Papanicolaou GA, Medeires AA, Eliopoulou GM, Moellering RC Jr, Jocoby GA. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990;34:2193-9.
5. Rice LB, Ecktein EC, De Vente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996;23:118-124.
6. Naumovki L, Quinn JP, Miyashiro D, Patel M, Bush K, Singer SB, Graves D, Palekill T, Arvin AM. Outbreak of ceftazidime resistance due to a novel extended-spectrum β-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 1992;36:1991-6.
7. Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2002;21:455-8.
8. Pallares R, Pujol M, Pena C, Ariea J, Martin R, Gudiol F. Cephalosporins as a risk factor for nosocomial Enterococcus faecalis bacteremia: a matched case-control study. Arch Intern Med. 1993;153:1581-6.
9. Piroth L, Aube H, Doise JM, Vincent-Martin M. Spread of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: are β-lactamase inhibitors of therapeutic value? Clin Infect Dis 1998;27:76-80.
10. Rice LB, Carias LL, Shales DM. In vivo efficacies of β-lactamase inhibitor combinations agent a TEM-26-producing strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 1994;38:2663-4.
11. Hellinger WC, Brewer NS. Carbapenems and monobactams: imipenem, meropenem and aztreonam. Mayo Clin Proc 1999;74:420-34.
12. Nathwani D, Wood MJ. Penicillins: a current review of their clinical pharmacology and the therapeutic use. Drugs 1993;45:866-94.
13. Monnet DL, Buddke JW, Edwards JR, Culver DH, Tolson JS, Martone WJ, Tenover FC, Gaynes RP. Evidence of interhospital transmission of extended-spectrum β-lactam resistant Klebsiella pneumoniae in the United States 1986 to 1993. Infect Control Hosp Epidemiol 1997;18:492-8.
14. Sader HS, Pfaller MA, Jones RN. Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States II: study of the intra- and inter-laboratory dissemination of extended-spectrum β-lactamase-producing Enterobacteriaceae. Diagn Microbiol Infect Dis 1994;20:203-8.
15. Shannon K, Stapleton P, Xiang X, Johnson A, Beattie H, El Bakri F, Cookson B, French G. Extended spectrum β-lactamase producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom. J Clin Microbiol 1998;36:3105-10.
16. Chanal CM, Sirot DL, Petit A, Labia R, Morand A, Sirot JL, Cluzel RA. Multiplicity of TEM-derived β-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids. Antimicrob Agents Chemother 1989;33:1915-20.